Short Description Stem‑cell entrepreneur founding Geron, ACT, and AgeX.
Description Dr. Michael West commercialized telomerase activation and embryonic stem‑cell therapies, founding Geron Corporation in 1990. He later led Advanced Cell Technology (ACT) to the first human embryonic stem‑cell clinical trial and now heads AgeX Therapeutics targeting induced tissue regeneration. West authors books on immortality science and advises policy‑makers on ethical regenerative medicine.